Jenna Sheridan, PA
Surgical · Boston, MANPI 1912367517
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,527 of the $3,987 with a category attached, or 88.5%. 19 manufacturers reported payments, led by Johnson & Johnson at 31.8% of the total. 2025 is the largest year on record at $1,508, more than ten times the $17 reported in 2022. Among surgical clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 144 payments — averaging $27.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Incyte Corporation$407
- Lilly USA, LLC$391
- AbbVie$348
- Sanofi$319
- Sun Pharmaceutical Industries Inc.$172
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,52788%
- Education$46012%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 33 | $1,268 |
| Incyte Corporation | 17 | $407 |
| Lilly USA, LLC | 23 | $391 |
| AbbVie | 21 | $348 |
| Sanofi | 5 | $319 |
| Sun Pharmaceutical Industries Inc. | 9 | $172 |
| E.r. Squibb & Sons, L.L.C. | 7 | $152 |
| UCB, Inc. | 2 | $144 |
| Amgen | 5 | $142 |
| Regeneron Healthcare Solutions, Inc. | 4 | $131 |
| Novartis | 5 | $129 |
| Arcutis Biotherapeutics, Inc. | 1 | $109 |
| Galderma Laboratories, L.p. | 5 | $94 |
| Pfizer | 2 | $62 |
| Bristol Myers Squibb | 1 | $31 |
| Boehringer Ingelheim | 1 | $30 |
| LNHC, Inc | 1 | $24 |
| Biofrontera Inc. | 1 | $17 |
| Organon | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,987 in reported general payments places this provider in the 95th percentile of 312 surgical providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 18 | $2,159 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 48 | $1,984 |
| Betamethasone Dipropionate | 49 | $1,927 |
| Ketoconazole | 38 | $671 |
| Triamcinolone Acetonide | 37 | $626 |
| Alclometasone Dipropionate | 16 | $496 |
Paid to pharmacies, not to this prescriber.
Other surgical in Boston
- Michael LlewellynBoston$8K
- Dana GoldenseBoston$5K
- Madison AltwiesBoston$5K
- Khare WilsonBoston$2K
- John MacropoulosBoston$2K
- Emilia FuscoBoston$1K
- Natalie BreedenBoston$1K
- Alexandra JurellerBoston$1K
- Gregory DeconciliisWaltham$27K
- Lampros MinosWaltham$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.